58 results in Exploration of Endocrine and Metabolic Diseases
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Commentary
Treating obesity with GLP-1 RAs: does sex matter? A commentary on the meta-analysis by Yang et al. (J Diabetes 2025;17(3):e70063)
Ralf Weiskirchen, Amedeo Lonardo
Published: February 02, 2026 Explor Endocr Metab Dis. 2026;3:101458
Open Access
Review
Impaired cytokines in diabetes and diabetic foot ulcers: mechanisms and prospects
Arbab Alam ... Vikrant Rai
Published: January 21, 2026 Explor Endocr Metab Dis. 2026;3:101457
This article belongs to the special issue Role of Dysregulated Cytokine Signaling Pathways in Metabolic Disease
Open Access
Review
Osteoporosis: definition, diagnosis, and considerations prior to starting treatment
Maritza Vidal, Nancy E. Lane
Published: January 09, 2026 Explor Endocr Metab Dis. 2026;3:101456
Open Access
Meta-Analysis
Association between APOA1 gene (rs670) single-nucleotide polymorphism and dyslipidaemia: a systematic review and meta-analysis
Cauan Farias Ananias ... Tiago Lima Sampaio
Published: January 09, 2026 Explor Endocr Metab Dis. 2026;3:101455
Open Access
Review
Cardiovascular effects of endocrine hypertension: insights from primary aldosteronism, pheochromocytoma, and Cushing syndrome
Mehmet Murat Şahin ... Yusuf Karavelioğlu
Published: January 08, 2026 Explor Endocr Metab Dis. 2026;3:101454
Open Access
Review
A novel therapeutic strategy of obesity from the perspective of SPMs
Ze-Wei Zhao
Published: January 05, 2026 Explor Endocr Metab Dis. 2026;3:101453
Open Access
Review
Effects of GLP-1 receptor agonists and dual incretin agonists on adipocyte type and size
Nino Turashvili
Published: December 18, 2025 Explor Endocr Metab Dis. 2025;2:101452
Open Access
Review
Glucocorticoid receptor alpha as a core survival receptor: mechanisms, and implications for health and critical illness
G. Umberto Meduri
Published: December 01, 2025 Explor Endocr Metab Dis. 2025;2:101451
Open Access
Review
Psychotropic medications and metabolic side effects
Michael Natalizio ... Vikrant Rai
Published: November 24, 2025 Explor Endocr Metab Dis. 2025;2:101450
This article belongs to the special issue Regulators of Glucose Homeostasis, Lipid Metabolism and Energy Balance
Open Access
Commentary
The pharma race to develop increasingly more potent incretin-based therapeutics—what is for the clinicians to know
Jerzy W Kolaczynski, Eva Surmacz
Published: November 14, 2025 Explor Endocr Metab Dis. 2025;2:101449
This article belongs to the special issue Regulators of Glucose Homeostasis, Lipid Metabolism and Energy Balance
Open Access
Original Article
Modeling the progression of NAFLD: a multi-state Markov approach based on BMI classification in the Chinese population
Jianmin Tang ... Xinghua Yang
Published: November 13, 2025 Explor Endocr Metab Dis. 2025;2:101448
Open Access
Review
Hormonal changes during aging and their effects on quality of life
Carter Coggins ... Vikrant Rai
Published: November 10, 2025 Explor Endocr Metab Dis. 2025;2:101447
This article belongs to the special issue The Fountain of Youth: Decoding the Hormonal Regulation of Aging
Open Access
Review
Diabetes mellitus and hepatosteatosis: a narrative review
Mehmet Ali Kosekli
Published: November 10, 2025 Explor Endocr Metab Dis. 2025;2:101446
This article belongs to the special issue Current Views on Pathogenesis, Diagnosis and Management of Type 2 Diabetes Mellitus and Its Complications and Related Conditions
Open Access
Short Communication
Pharmacological inhibition of type 5 adenylyl cyclase, a model for healthful aging, enhanced exercise capacity and glucose tolerance
Dorothy E. Vatner ... Stephen F. Vatner
Published: November 05, 2025 Explor Endocr Metab Dis. 2025;2:101445
This article belongs to the special issue Innovative Strategies for Diabetes and Metabolic Disorders: Current and Future Directions
Open Access
Review
Disruption of the transsulfuration pathway as a sulfur-driven etiology of insulin resistance: proinsulin misfolding, disulfide bond deformation, and PDI dysregulation
Maher Monir Akl, Amr Ahmed
Published: November 03, 2025 Explor Endocr Metab Dis. 2025;2:101444
This article belongs to the special issue Current Views on Pathogenesis, Diagnosis and Management of Type 2 Diabetes Mellitus and Its Complications and Related Conditions
Open Access
Systematic Review
Clinical management strategies for type 2 diabetes mellitus with metabolic dysfunction-associated fatty liver disease: an umbrella review of systematic reviews and meta-analyses
Huiling Huang ... Dongsheng Li
Published: October 23, 2025 Explor Endocr Metab Dis. 2025;2:101443
This article belongs to the special issue Innovative Strategies for Diabetes and Metabolic Disorders: Current and Future Directions
Open Access
Systematic Review
Gestational diabetes mellitus in India: metabolic burden, clinical gaps, and therapeutic opportunities—a systematic review
Sumedha Rajendra Zade ... Rekha Mehani
Published: October 17, 2025 Explor Endocr Metab Dis. 2025;2:101442
Open Access
Original Article
Baicalin and ginsenoside Rb1 regulate the expression of adipocyte GRK2 and browning markers under lipid overload
Zhuqi Wang ... Kang Liu
Published: October 13, 2025 Explor Endocr Metab Dis. 2025;2:101441
This article belongs to the special issue Regulators of Glucose Homeostasis, Lipid Metabolism and Energy Balance
Open Access
Review
Metabolic syndrome in menopause
Nagamani Gumpeny ... Sridhar R. Gumpeny
Published: September 24, 2025 Explor Endocr Metab Dis. 2025;2:101440
This article belongs to the special issue Metabolic Syndrome in Menopause
Open Access
Systematic Review
Taste genomics and type 2 diabetes mellitus: a systematic qualitative meta-synthesis
Vishnu Shivam ... Vishnu Harish
Published: August 07, 2025 Explor Endocr Metab Dis. 2025;2:101439
PreviousJournal Information